There’s a new $16,000 drug to treat postpartum depression. Will insurers cover it?
-----
A much-awaited treatment for postpartum depression, zuranolone, hit the market in December, promising an accessible and fast-acting medication for a debilitating illness. But most private health insurers have yet to publish criteria for when they will cover it, according to a new analysis of insurance policies.The lack of guidance could limit use of the drug, which is both novel — it targets hormone function to relieve symptoms instead of the brain's serotonin system, as typical
